Defining Biliary Hyperkinesia and the Role of Cholecystectomy

Akash Kartik1, Irving A Jorge2, Christopher Webb2

  • 1From the Department of Surgery, Tulane University, New Orleans, LA (Kartik).

Insights

An ejection fraction (EF) cutoff of 81% on gallbladder scans may indicate biliary hyperkinesia. Cholecystectomy is recommended for patients with biliary symptoms and an EF above 81% for pain resolution.

Area of Science:

  • Gastroenterology
  • Hepatobiliary Surgery

Background:

  • Functional gallbladder disorder is often diagnosed by biliary colic and low gallbladder ejection fraction (EF) on cholescintigraphy.
  • Biliary hyperkinesia, a type of functional gallbladder disorder, has an unclear definition and treatment role for cholecystectomy.

Purpose of the Study:

  • To determine the optimal ejection fraction (EF) cutoff for predicting symptom resolution after cholecystectomy in patients with biliary hyperkinesia.
  • To establish a diagnostic criterion for biliary hyperkinesia.

Main Methods:

  • Retrospective review of patients undergoing cholecystokinin-stimulated cholescintigraphy and cholecystectomy (2007-2020).
  • Analysis included patients aged 18+ with biliary symptoms, EF >50%, and no acute cholecystitis or cholelithiasis.
  • Receiver operating characteristics curve analysis identified the optimal EF cutoff for predicting symptom resolution.

Main Results:

  • 1,596 patients had EF ≥50%, with 141 (8.8%) undergoing cholecystectomy.
  • An EF cutoff of 81% significantly predicted pain resolution post-cholecystectomy (78.2% vs. 60.0%, p=0.03).
  • Chronic cholecystitis was found in 61.7% of patients on final pathology.

Conclusions:

  • An EF of 81% is proposed as the upper limit of normal gallbladder EF.
  • Patients with biliary symptoms and EF >81% without other biliary disease evidence may have biliary hyperkinesia.
  • Cholecystectomy is recommended for patients diagnosed with biliary hyperkinesia based on these findings.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
490
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
164
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
436
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
150
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
116